GSThe Goldman Sachs Group, Inc.
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $17.01Beat
- vs $12.90 expected on Oct 13
- Stock move on it
- −0.23%
- one session
- Typical move
- ±4.6%
- average over 2 reports
- Price
- $913.61
- −1.42% today · $289B cap
Past and upcoming reports
2
| Oct 13, 2026 | Sep 30, 2026 | Time not given | $12.90 | Beat$17.01 | −0.23% |
| Jul 14, 2026 | Jun 30, 2026 | Time not given | $13.72 | Beat$20.98 | +9.00% |
After the report
Jul 14, 2026 report
This covers the Jul 14, 2026 report. The Oct 13, 2026 numbers are in the table above.
Goldman Sachs beats by 45% but stock slides 2.8% as profit-taking emerges
GS reported Q2 2026 EPS of $20.98, a 45% beat over the $14.47 consensus, driven by strong capital markets activity. Despite the record quarter, the stock fell 2.76% to $1,065.22 three days post-print, suggesting the market views this as peak earnings and rotates out of the name.
Reported against expected
BeatEPS of $20.98 beat the $14.47 estimate by 45% ($6.51 surprise).
Guidance
No explicit forward guidance in payload. stock_intelligence flags risk of fading euphoria and insider selling.
How the stock reacted
Stock fell 2.76% to $1,065.22 on July 17, three days after the print, despite the beat.
What changed
EPS surged 45% above consensus, marking a record quarter for GS.
What the price now assumes
Stock decline suggests market sees this as peak earnings, with insider selling and sector rotation weighing.
What it means for the business
Upgrade bias on earnings power but monitor next quarter's revenue mix and capital markets activity.
The next one to three months, as we saw it then
Better case30%
Capital markets upcycle continues, driving further revenue and EPS beats. GS re-rates toward analyst high target of $1,325.
Base case45%
Earnings stabilize near current run-rate. stock trades around analyst target of $1,170 as market digests the record quarter.
Worse case25%
Post-earnings euphoria fades. sector enters topping phase and insider selling pressures stock toward analyst low of $955.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.